"Antigma-M" Reagent Kit for Enzyme-Linked Immunosorbent Detection of IgM Antibodies to SARS-CoV-2 (According to TU 21.20.23-073-26329720-2020)

"Antigma-M" Reagent Kit for Enzyme-Linked Immunosorbent Detection of IgM Antibodies to SARS-CoV-2 (According to TU 21.20.23-073-26329720-2020)

The "Antigma-M" reagent kit is designed for the enzyme-linked immunosorbent assay (ELISA) to detect M class antibodies (IgM) specific to the SARS-CoV-2 virus.

Technical Specifications: TU 21.20.23-073-26329720-2020

Kit Configuration: 3 plates × 96 determinations

Kit Components:

• "Immunosorbent" – 1 unit
• "K+" – Positive control sample, inactivated, 1.5 ml – 1 vial
• "K–" – Negative control sample, inactivated, 3.0 ml – 1 vial
• "RBR-S" – Serum dilution buffer, 12.0 ml – 1 vial
• "RK" – Conjugate solution, 13.0 ml – 1 vial
• "BRS" – Substrate buffer solution, 13.0 ml – 1 vial
• "TMB" – Tetramethylbenzidine, 1.0 ml – 1 vial
• "FSB-T(x25)" – 25x concentrate of phosphate-saline buffer with Tween, 28.0 ml – 1 vial
• "Stop Reagent" – 0.9 mol/L sulfuric acid solution, 6.0 ml – 1 vial
• Protective film for microplates – 2 pcs
• Reagent tray – 2 pcs
• Disposable polymer pipette tips (0.5–250 µl range) – 16 pcs
• Operational documentation including instructions for use with appendix – 1 set

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, "Antigma-M" Reagent Kit for Enzyme-Linked Immunosorbent Detection of IgM Antibodies to SARS-CoV-2 (According to TU 21.20.23-073-26329720-2020), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.